TELA Bio Presents Additional Data from BRAVO Study of OviTex® for Ventral Hernia Repair
MALVERN, Pa., Sept. 25, 2020 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on designing, […]
Axogen, Inc. to Present at the JMP Securities MedTech Bio Summit
ALACHUA, Fla., Sept. 25, 2020 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative […]
PINTEC Announces Results of 2020 Extraordinary General Meeting
BEIJING, Sept. 25, 2020 (GLOBE NEWSWIRE) — Pintec Technology Holdings Limited (Nasdaq: PT) (“PINTEC” or the “Company”), a leading independent […]
Enphase Energy Welcomes Christopher Landau, U.S. Ambassador to Mexico, to Made in Mexico Event
FREMONT, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the […]
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference
LONDON, Sept. 25, 2020 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully […]
Aesthetic Medical International Holdings Group Limited Reports Second Quarter 2020 Unaudited Financial Results
Shenzhen, China, Sept. 25, 2020 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a […]
Johnson Outdoors Announces Cash Dividend Increase
RACINE, Wisc., Sept. 25, 2020 (GLOBE NEWSWIRE) — Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor recreation equipment and […]
Genetron Health and CStone Pharmaceuticals Announce Launch of Clinical Trial in China for Companion Diagnostic Test in Development for Avapritinib
BEIJING and SUZHOU, China, Sept. 25, 2020 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health”, Nasdaq: GTH), a leading precision […]
GeoVax Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split
ATLANTA, GA, Sept. 24, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), […]
Prelude Therapeutics Announces Pricing of Initial Public Offering
WILMINGTON, Del., Sept. 24, 2020 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced […]
